Subscribe to Newsletter

Discovery & Development

Discovery & Development Ingredients

Manufacturers Urged to Take Steps to Avoid DEG and EG Contamination

| Stephanie Vine | 4 min read

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.

Discovery & Development Drug Discovery

QTOF: Quick Off the Mark for Oligonucleotide Analysis

| Timo Schierling, Julia Schneider, Stephan Seiffert, Christian Albers | 4 min read

Experts from Axolabs GmbH and Bruker Daltonics explain the benefits behind mass spectrometry for oligonucleotides in drug discovery

Discovery & Development Drug Delivery

Creating CRISPR Chickens

| Jamie Irvine | 4 min read

Researchers genetically modify chickens to build bird-flu resistance – read more here.

Discovery & Development Clinical Trials

Body Positive

| Rob Coker | 2 min read

Almirall’s humanized monoclonal antibody treatment for psoriasis brings positivity for patients

Discovery & Development Drug Discovery

SMM Screening

| 5 min read

Why small molecule microarrays are leading the way in small molecule drug discovery

Discovery & Development Drug Discovery

The Cardiovascular Regulators

| Jamie Irvine | 5 min read

Scientists unearth new molecular targets on AT1R that could lead to improved drugs for heart disease

Discovery & Development Drug Discovery

Reaching for RNA

| Stephanie Vine | 7 min read

The COVID-19 pandemic has helped propel the RNA field forward, but manufacturing and funding challenges lie ahead.

Discovery & Development Drug Discovery

Science Fiction Comes to Life

| Rob Coker | 3 min read

Researchers are working on ways to introduce nanoscale artificial life-forms to viruses with the aim of mimicking the human immune system

Discovery & Development Formulation

The Sulforaphane Promise

| Helen Kuhlman | 4 min read

Sulforaphane has therapeutic potential in numerous areas but formulation is key. Can enteric coatings help find the way forward?

Discovery & Development Drug Discovery

New Antibiotic on the Block

| Jamie Irvine | 2 min read

New antibiotic candidate Clovibactin eliminates bacteria without developing resistance

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register